Abstract
Neuroblastoma (NB) is known as a pediatric neoplasm that is associated with variable histopathological features. The use of biomarkers contributes to the monitoring and treatment of various malignancies such as NB. The identification of novel biomarkers such as (epi)genetic biomarkers and microRNAs (miRNAs) in NB has led to better treatments of NB. Among them, miRNAs have emerged as powerful tools in diagnosis, prognosis and therapeutic biomarkers for patients with NB. Circulating biomarkers such as circulating miRNAs present in body fluids (for example, plasma, serum and urine) provided an interesting field of study in NB treatment. The miRNAs have central roles in different pathogenic events in various malignancies such as NB. Hence, these molecules can be a suitable candidate for monitoring and treating NB patients. Here, we summarize some miRNAs as potential prognosis, diagnosis and therapeutic biomarkers in NB.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fcgt.2016.45/MediaObjects/41417_2016_Article_BFcgt201645_Fig1_HTML.jpg)
Similar content being viewed by others
References
Zhu S, Lee J-S, Guo F, Shin J, Perez-Atayde AR, Kutok JL et al. Activated ALK collaborates with MYCN in neuroblastoma pathogenesis. Cancer Cell 2012; 21: 362–373.
Brodeur GM . Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3: 203–216.
Gholamin S, Pasdar A, Sadegh Khorrami M, Mirzaei H, Reza Mirzaei H, Salehi R et al. The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment. Curr Pharm Des 2016; 22: 397–403.
Mirzaei H, Gholamin S, Shahidsales S, Sahebkar A, Jafaari MR, Mirzaei HR et al. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. Eur J Cancer 2016; 53: 25–32.
Simonian M, Mosallayi M, Mirzaei H . Circulating miR-21 as novel biomarker in gastric cancer: diagnostic and prognostic biomarker. J Cancer Res Ther 2016. (e-pub ahead of print).
Reza Mirzaei H . Circulating microRNAs in hepatocellular carcinoma: potential diagnostic and prognostic biomarkers. Curr Pharm Des 2016. (e-pub ahead of print).
Salarini R, Sahebkar A, Mirzaei H, Jaafari M, Riahi M, Hadjati J et al. Epi-drugs and epi-miRs: moving beyond current cancer therapies. Curr Cancer Drug Targets 2015. (e-pub ahead of print; 6 December 2015).
Ghossein RA, Bhattacharya S, Rosai J . Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 1999; 5: 1950–1960.
Ramraj SK, Pandian V, Khan FH, Aravindan S, Herman TS, Natarajan M et al. Profiling of circulating miRNAs is a critical prognostic biomarker tool for high-risk neuroblastoma. Cancer Res 2014; 74: 5229.
Combaret V, Bergeron C, Bréjon S, Iacono I, Perol D, Négrier S et al. Protein chip array profiling analysis of sera from neuroblastoma patients. Cancer Lett 2005; 228: 91–96.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Mohammadi, M., Goodarzi, M., Jaafari, M. et al. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma. Cancer Gene Ther 23, 371–372 (2016). https://doi.org/10.1038/cgt.2016.45
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2016.45
This article is cited by
-
A label-free electrochemical biosensor based on PBA-Au-MXene QD for miR-122 detection in serum samples
Microchimica Acta (2023)
-
FGFR1 is a potential therapeutic target in neuroblastoma
Cancer Cell International (2022)
-
NEAT1 in bone marrow mesenchymal stem cell-derived extracellular vesicles promotes melanoma by inducing M2 macrophage polarization
Cancer Gene Therapy (2022)
-
Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches
Cancer Cell International (2020)
-
Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion
Cellular & Molecular Biology Letters (2019)